NTAP
60
2
CNX
80
4
NVDA
52
-3
CFG
38
-2
CF
57
-3
OMC
64
-2
AN
50
-5
MU
34
3
IPG
39
-3
IP
39
-6
EBAY
47
-2
ESS
60
-8
ADM
33
-3
AME
57
-2
ZTS
56
-2
FTI
82
4
ED
53
4
MCD
67
2
IR
72
-5
PG
51
3
NTAP
60
2
CNX
80
4
NVDA
52
-3
CFG
38
-2
CF
57
-3
OMC
64
-2
AN
50
-5
MU
34
3
IPG
39
-3
IP
39
-6
EBAY
47
-2
ESS
60
-8
ADM
33
-3
AME
57
-2
ZTS
56
-2
FTI
82
4
ED
53
4
MCD
67
2
IR
72
-5
PG
51
3
Financhill
Back

CASI Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
48

CASI
CASI Pharmaceuticals

Last Price:
6.33
Seasonality Move:
9.09%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
48
CASI Pharmaceuticals (CASI) is a Sell

Is CASI Pharmaceuticals a Buy, Sell or Hold?

  • The current CASI Pharmaceuticals [CASI] share price is $6.47. The Score for CASI is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CASI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CASI Stock Price Chart

What is CASI Pharmaceuticals's stock price today?

  • The CASI Pharmaceuticals share price today is $6.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CASI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 45.41 Sell
Chaikin Money Flow: -3012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.38 - 7) Sell
Bollinger Bands (100): (3.49 - 6.85) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CASI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.94 Sell
20-day SMA: 6.74 Sell
50-day SMA: 6.62 Sell
200-day SMA: 5.13 Buy
8-day EMA: 6.76 Sell
20-day EMA: 6.75 Sell
50-day EMA: 6.35 Buy
200-day EMA: 5.04 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

CASI Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):